# Study of FORTEO Use in Subjects in the Community Setting

> **NCT01078805** · — · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 4167 (actual)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** FORTEO

## Key facts

- **NCT ID:** NCT01078805
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2003-08
- **Primary completion:** 2011-02
- **Final completion:** 2011-02
- **Target enrollment:** 4167 (ACTUAL)
- **Last updated:** 2012-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01078805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01078805, "Study of FORTEO Use in Subjects in the Community Setting". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01078805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*